Table 1.
Candidate genes, primer sequences, and PCR efficiency.
| Symbol | Ensembl gene ID | Forward primer | Reverse primer | Amplicon size (bp) | Exon location | PCR efficiency (%) |
|---|---|---|---|---|---|---|
| RBM45 | ENSG00000155636 | CCAAGGAGTCCAAGGGCATT | CCAGATGATCGGGACTGAGC | 145 | Intron-flank, 1st, 2nd | 100 |
| NRF1 | ENSG00000106459 | GGTCGCAGTCTCCACGG | TTTGGGTCACTCCGTGTTCC | 79 | Intron-flank, 1st, 2nd | 105 |
| BRAP | ENSG00000089234 | CGGCCGGGGAAATGTCT | TACTTCTTTGCGCAGTGGGG | 231 | Intron-span, 1st, 3rd | 108 |
| WDR33 | ENSG00000136709 | TGGGGAGTTTACCCTGTGGA | ACATATCCTCCGTGGTCTGC | 135 | Intron-flank, 5th, 6th | 106 |
| CNOT2 | ENSG00000111596 | ACTACCAGGTGACAAACAGC | TAGTCACTGTCGACCCCCTC | 70 | Intron-flank, 3rd, 4th | 107 |
| TIAL1 | ENSG00000151923 | CCCTGAGGTGGACCACATTT | AAGCGACTCCAAAATCACGC | 78 | Exonic, 13th | 107 |
| CIAO1 | ENSG00000144021 | TTGGGTCTGGGAAGTTGATGA | CTCAAGGGTGGCACAGCATA | 187 | Intron-span, 3rd, 6th | 95 |
| TARDBP | ENSG00000120948 | TCGGGGACCTCCAAAGACTA | AACCATGCCGTTGACAAGTT | 75 | Exonic, 6th | 105 |
| ZNF207 | ENSG00000010244 | CAAAGTGGATGCCAACTGCC | CCAAAGTTGCCAGCCCTACT | 117 | Exonic, 11th | 98 |
| HNRNPK | ENSG00000165119 | GTCTCGCGCGGCTACTG | CCCCAGCATTCTTGCTCTGA | 283 | Intron-span, 1th, 5th | 97 |
| UBC* | ENSG00000150991 | ACGGGACTTGGGTGACTCTA | ATCGCCGAGAAGGGACTACT | 82 | Exonic, 1st | 108 |
| ACTB*,**,# | ENSG00000075624 | GAAGATCAAGATCATTGCTCCT | TACTCCTGCTTGCTGATCCA | 111 | Intron-span, 5th, 6th | 91.8 |
| PUM1*,***,## | ENSG00000134644 | TGCGGGAGATTGCTGGACAT | GTGTGGCACGCTCCAGTTTC | 87 | Intron-flank, 15th, 16th | 98.4 |
| RPN1* | ENSG00000163902 | CTGACTGTGAAGATCATCCTGCC | GTCCAGATAGGTGTAGTGCAGC | 105 | Intron-flank, 6th, 7th | 102 |
| RPL13A*,# | ENSG00000142541 | CGAGGTTGGCTGGAAGTACC | CTTCTCGGCCTGTTTCCGTAG | 121 | Intron-flank, 6th, 7th | 103 |
| PPIA**,# | ENSG00000196262 | TCCTGGCATCTTGTCCAT | TGCTGGTCTTGCCATTCCT | 179 | Intron-flank, 5th, 6th | 107 |
| PGK1**,# | ENSG00000102144 | GCCACTTGCTGTGCCAAATG | CCCAGGAAGGACTTTACCTT | 102 | Intron-span, 10th, 11th | 139 |
| IPO8***,## | ENSG00000133704 | GGCATACAGTTTAACCTGCCAC | CAGGAGAGGCATCATGTCTGTAA | 118 | Intron-flank, 14th, 15th | 92.5 |
| HNRNPL***,## | ENSG00000104824 | CCAAGGCCTCTCTCAATGGG | TTCAAGCGTGTAGGCTTTGC | 82 | Intron-span, 5th, 6th | 97.9 |
| SNW1***,## | ENSG00000100603 | GCAGCTCCTGATAAGAGGTCG | CCGAGGATTAGGAACACCGAG | 87 | Intron-span, 11th, 12th | 95.8 |
| CNOT4***,## | ENSG00000080802 | GTCCAAAACCTGACTGCATGTATC | GGTGTTTACCCGCCTGCAT | 87 | Intron-span, 7th, 8th | 96.3 |
One to 10 candidate genes from reference (16).
*Five recommended stable reference genes for LUAD from reference (Krasnov, Kudryavtseva et al., 2019).
**Three recommended stable reference genes for lung cancer from reference (Ali, Du et al., 2015).
***Five recommended stable reference genes for human cancer and normal cell lines from reference (Racz, Nagy et al., 2021).
#Primers from reference (Ali, Du et al., 2015).
##Primers from reference (Racz, Nagy et al., 2021).
UBC primers from reference (Augustyniak, Lenart et al., 2019) and RPN1 primers from OriGen.